Anti-GPRC5D iPSC-Derived CAR-NK Product(Cell Inspire Therapeutics)

N/A

Report date: 2024/12/25 17:31:32

Base Information

Drug NameAnti-GPRC5D iPSC-Derived CAR-NK Product(Cell Inspire Therapeutics)
Drug Alias NameCIB-315CIB315
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionG-protein coupled receptor family C group 5member D modulatorsNatural killer cell replacements
TargetsG-protein coupled receptor family C group 5member D
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCell Inspire Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCell Inspire Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A